Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Hu, Fuliang ^a   Li, Yajing ^b   Chen, Minli ^c   Xuan, Hongzhuan ^d  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhejiang Economic and Trade Polytechnic ^*  (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d LIAOCHENG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; PROPOLIS; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENCAPSULATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 80052666648     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/981896     Document Type: Article

References (36)

1. King H., Aubert R. E., Herman W. H., Global burden of diabetes, 19952025: prevalence, numerical estimates, and projections Diabetes Care 1998 21 9 1414 1431 (Pubitemid 28405191)
2. Ministry of Health Peoples Republic of China MoSaToPRoC, National Bureau of Statistics of China, An Investigation on Health and Nutrition Status of Chinese Resident 2005 Beijing, China People's Health Publishing House
3. Wild S., Roglic G., Green A., Sicree R., King H., Global Prevalence of Diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27 5 1047 1053 (Pubitemid 38579764)
4. Dav G., Santilli F., Patrono C., Nutraceuticals in diabetes and metabolic syndrome Cardiovascular Therapeutics 2010 28 4 216 226
5. Jermendy G., Can type 2 diabetes mellitus be considered preventable? Diabetes Research and Clinical Practice 2005 68 supplement 1 S73 S81 (Pubitemid 40812360)
6. Khalil M. L., Biological activity of bee propolis in health and disease Asian Pacific Journal of Cancer Prevention 2006 7 1 22 31
7. Medi-ari M., Rastija V., Boji M., Male Z., From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine Nutrition Journal 2009 8 1, article 33
8. Banskota A. H., Tezuka Y., Kadota S., Recent progress in pharmacological research of propolis Phytotherapy Research 2001 15 7 561 571 (Pubitemid 33021859)
9. Burdock G. A., Review of the biological properties and toxicity of bee propolis (propolis) Food and Chemical Toxicology 1998 36 4 347 363 (Pubitemid 28255348)
10. Castaldo S., Capasso F., Propolis, an old remedy used in modern medicine Fitoterapia 2002 73 supplement 1 S1 S6 (Pubitemid 35472198)
11. Murata K., Yatsunami K., Fukuda E., Onodera S., Mizukami O., Hoshino G., Kamei T., Antihyperglycemic effects of propolis mixed with mulberry leaf extract on patients with type 2 diabetes Alternative Therapies in Health and Medicine 2004 10 3 78 79 (Pubitemid 38620829)
12. Matsui T., Ebuchi S., Fujise T., Abesundara K. J. M., Doi S., Yamada H., Matsumoto K., Strong antihyperglycemic effects of water-soluble fraction of Brazilian propolis and its bioactive constituent, 3,4,5-tri-O-caffeoylquinic acid Biological and Pharmaceutical Bulletin 2004 27 11 1797 1803 (Pubitemid 41701607)
13. Abo-Salem O. M., El-Edel R. H., Harisa G. E. I., El-Halawany N., Ghonaim M. M., Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic disturbances and renal oxidative parameters Pakistan Journal of Pharmaceutical Sciences 2009 22 2 205 210
14. McLennan S. V., Bonner J., Milne S., Lo L., Charlton A., Kurup S., Jia J., Yue D. K., Twigg S. M., The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes Wound Repair and Regeneration 2008 16 5 706 713
15. Lotfy M., Badra G., Burham W., Alenzi F. Q., Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus British Journal of Biomedical Science 2006 63 4 171 173 (Pubitemid 46033477)
16. Okutan H., Ozcelik N., Ramazan Yilmaz H., Uz E., Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart Clinical Biochemistry 2005 38 2 191 196 (Pubitemid 40092465)
17. Kang L.-J., Lee H. B., Bae H.-J., Lee S.-G., Antidiabetic effect of propolis: reduction of expression of glucose-6-phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3 / in HepG2 cells Phytotherapy Research 2010 24 10 1554 1561
18. Zhu W., Li Y. H., Chen M. L., Hu F. L., Protective effects of Chinese and Brazilian propolis treatment against hepatorenal lesion in diabetic rats. Human Experimental Toxicology. In press
19. Fuliang H. U., Hepburn H. R., Xuan H., Chen M., Daya S., Radloff S. E., Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus Pharmacological Research 2005 51 2 147 152 (Pubitemid 40040545)
20. Zhu W., Chen M., Shou Q., Li Y., Hu F., Biological activities of Chinese propolis and Brazilian propolis on streptozotocin-induced type 1 diabetes mellitus in rats Evidence-Based Complementary and Alternative Medicine 2011 2011 8
21. Sforcin J. M., Bankova V., Propolis: is there a potential for the development of new drugs? Journal of Ethnopharmacology 2011 133 2 253 260
22. Kalogeropoulos N., Konteles S., Mourtzinos I., Troullidou E., Chiou A., Karathanos V. T., Encapsulation of complex extracts in -cyclodextrin: an application to propolis ethanolic extract Journal of Microencapsulation 2009 26 7 603 613
23. Yajing Li F. H., Pharmaceutical char acter istics of nanometer propolis in vitro Apiculture of China 2007 58 5 7
24. Ramadan W., Dewasmes G., Petitjean M., Loos N., Delanaud S., Geloen A., Libert J. P., Spontaneous motor activity in fat-fed, streptozotocin-treated rats: a nonobese model of type 2 diabetes Physiology and Behavior 2006 87 4 765 772 (Pubitemid 46137886)
25. Guangwei L., Bennett P. H., Regarding the reverse of the product of fasting plasma glucose and insulin levelsAdditional remarks of an insulin sensitivity index used in epidemiological study Chinese Journal of Diabetes 2005 13 247 249
26. Kuhlmann J., Neumann-Haefelin C., Belz U., Kramer W., Juretschke H. P., Herling A. W., Correlation between insulin resistance and intramyocellular lipid levels in rats Magnetic Resonance in Medicine 2005 53 6 1275 1282 (Pubitemid 40734646)
27. Zhang M., Lv X. Y., Li J., Xu Z. G., Chen L., The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model Experimental Diabetes Research 2008 2008 9
28. Nathan D. M., Buse J. B., Davidson M. B., Ferrannini E., Holman R. R., Sherwin R., Zinman B., Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: aonsensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 2009 52 1 17 30
29. Davidson J. A., Treatment of the patient with diabetes: importance of maintaining target HbA levels Current Medical Research and Opinion 2004 20 12 1919 1927 (Pubitemid 40179631)
30. Perez N., Moisan J., Sirois C., Poirier P., Grégoire J. P., Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs CMAJ 2009 180 13 1310 1316
31. Bailey C. J., Insulin resistance and antidiabetic drugs Biochemical Pharmacology 1999 58 10 1511 1520 (Pubitemid 29467335)
32. Kim J. K., Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo Methods in Molecular Biology 2009 560 221 238
33. McGarry J. D., Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 2002 51 1 7 18
34. Karasawa H., Nagata-Goto S., Takaishi K., Kumagae Y., A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice Metabolism: Clinical and Experimental 2009 58 3 296 303
35. Annuzzi G., De Natale C., Iovine C., Patti L., Di Marino L., Coppola S., Del Prato S., Riccardi G., Rivellese A. A., Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 12 2397 2402 (Pubitemid 39658048)
36. Watson K. E., Horowitz B. N., Matson G., Lipid abnormalities in insulin resistant states Reviews in Cardiovascular Medicine 2003 4 4 228 236 (Pubitemid 37536808)